Literature DB >> 22264985

Extension of Kaplan-Meier methods in observational studies with time-varying treatment.

Stanley Xu1, Susan Shetterly, David Powers, Marsha A Raebel, Thomas T Tsai, P Michael Ho, David Magid.   

Abstract

OBJECTIVES: Inverse probability of treatment weighted Kaplan-Meier estimates have been developed to compare two treatments in the presence of confounders in observational studies. Recently, stabilized weights were developed to reduce the influence of extreme inverse probability of treatment-weighted weights in estimating treatment effects. The objective of this research was to use adjusted Kaplan-Meier estimates and modified log-rank and Wilcoxon tests to examine the effect of a treatment that varies over time in an observational study.
METHODS: We proposed stabilized weight adjusted Kaplan-Meier estimates and modified log-rank and Wilcoxon tests when the treatment was time-varying over the follow-up period. We applied these new methods in examining the effect of an anti-platelet agent, clopidogrel, on subsequent events, including bleeding, myocardial infarction, and death after a drug-eluting stent was implanted into a coronary artery. In this population, clopidogrel use may change over time based on a patient's behavior (e.g., nonadherence) and physicians' recommendations (e.g., end of duration of therapy). Consequently, clopidogrel use was treated as a time-varying variable.
RESULTS: We demonstrate that 1) the sample sizes at three chosen time points are almost identical in the original and weighted datasets; and 2) the covariates between patients on and off clopidogrel were well balanced after stabilized weights were applied to the original samples.
CONCLUSIONS: The stabilized weight-adjusted Kaplan-Meier estimates and modified log-rank and Wilcoxon tests are useful in presenting and comparing survival functions for time-varying treatments in observational studies while adjusting for known confounders.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22264985      PMCID: PMC3267428          DOI: 10.1016/j.jval.2011.07.010

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  17 in total

1.  Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.

Authors:  Miguel A Hernán; Babette A Brumback; James M Robins
Journal:  Stat Med       Date:  2002-06-30       Impact factor: 2.373

2.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

3.  Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.

Authors:  Jun Xie; Chaofeng Liu
Journal:  Stat Med       Date:  2005-10-30       Impact factor: 2.373

4.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

5.  Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.

Authors:  Nancy R Cook; Stephen R Cole; Charles H Hennekens
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

6.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

7.  The effect of HIV infection on overdose mortality.

Authors:  Cunlin Wang; David Vlahov; Noya Galai; Stephen R Cole; Joseph Bareta; Robin Pollini; Shruti H Mehta; Kenrad E Nelson; Sandro Galea
Journal:  AIDS       Date:  2005-06-10       Impact factor: 4.177

8.  Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model.

Authors:  Stephen R Cole; Miguel A Hernán; Kathryn Anastos; Beth D Jamieson; James M Robins
Journal:  Am J Epidemiol       Date:  2007-05-02       Impact factor: 4.897

9.  The hazards of hazard ratios.

Authors:  Miguel A Hernán
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology.

Authors:  Lisa M Bodnar; Marie Davidian; Anna Maria Siega-Riz; Anastasios A Tsiatis
Journal:  Am J Epidemiol       Date:  2004-05-15       Impact factor: 4.897

View more
  12 in total

1.  The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068.

Authors:  Marie C D Stoner; Audrey Pettifor; Jessie K Edwards; Allison E Aiello; Carolyn T Halpern; Aimée Julien; Amanda Selin; Rhian Twine; James P Hughes; Jing Wang; Yaw Agyei; F Xavier Gomez-Olive; Ryan G Wagner; Catherine MacPhail; Kathleen Kahn
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

2.  Effect of Quality of Caregiver-Adolescent Relationship on Sexual Debut, Transactional Sex, and on Age-Disparate Relationships Among Young Women in Rural South Africa Enrolled in HPTN 068.

Authors:  Nosipho Shangase; Jess Edwards; Brian Pence; Allison Aiello; Andrea Hussong; Xavier Gómez-Olivé; Kathleen Kahn; Marie Stoner; Audrey Pettifor
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-01       Impact factor: 3.771

3.  Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa.

Authors:  Marie C D Stoner; Nadia Nguyen; Kelly Kilburn; F Xavier Gómez-Olivé; Jessie K Edwards; Amanda Selin; James P Hughes; Yaw Agyei; Catherine Macphail; Kathleen Kahn; Audrey Pettifor
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

4.  Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment.

Authors:  Stanley Xu; Susan Shetterly; Marsha A Raebel; P Michael Ho; Thomas T Tsai; David Magid
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-04       Impact factor: 2.890

5.  Displaying survival of patient groups defined by covariate paths: Extensions of the Kaplan-Meier estimator.

Authors:  Melissa Jay; Rebecca A Betensky
Journal:  Stat Med       Date:  2021-02-02       Impact factor: 2.373

Review 6.  Testosterone deficiency and cardiovascular mortality.

Authors:  Abraham Morgentaler
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

7.  Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods.

Authors:  Melissa H Roberts; Douglas W Mapel; Matthew E Borrego; Dennis W Raisch; Larry Georgopoulos; David van der Goes
Journal:  Drugs Real World Outcomes       Date:  2015-06

8.  Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma.

Authors:  Annalisa Pezzi; Michele Cavo; Annibale Biggeri; Elena Zamagni; Oriana Nanni
Journal:  BMC Med Res Methodol       Date:  2016-11-09       Impact factor: 4.615

9.  Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials.

Authors:  Akihiro Hirakawa; Kan Yonemori; Fumie Kinoshita; Yumiko Kobayashi; Hitomi S Okuma; Asuka Kawachi; Kenji Tamura; Yasuhiro Fujiwara; Larry Rubinstein; Pamela Jo Harris; Naoko Takebe
Journal:  Cancer Sci       Date:  2017-12-08       Impact factor: 6.716

10.  Transactional sex and incident HIV infection in a cohort of young women from rural South Africa.

Authors:  Kelly Kilburn; Meghna Ranganathan; Marie C D Stoner; James P Hughes; Catherine MacPhail; Yaw Agyei; F Xavier Gómez-Olivé; Kathleen Kahn; Audrey Pettifor
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.